New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
The prevalence of type 2 diabetes is increasing dramatically, and the pathogenesis of the disease has been studied extensively in recent years. Of particular interest, incretins are reported to cause changes in insulin secretion that affect the natural development of the disease. The emergence of ne...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5136acef822b45b6a6dddfc208a9d30d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5136acef822b45b6a6dddfc208a9d30d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5136acef822b45b6a6dddfc208a9d30d2021-11-14T09:00:19ZNew concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications2072-03512072-037810.14341/DM2015323-31https://doaj.org/article/5136acef822b45b6a6dddfc208a9d30d2015-10-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7125https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The prevalence of type 2 diabetes is increasing dramatically, and the pathogenesis of the disease has been studied extensively in recent years. Of particular interest, incretins are reported to cause changes in insulin secretion that affect the natural development of the disease. The emergence of new drugs that act via the incretin axis have led many clinicians to consider their place in clinical practice.Ivan Ivanovich DedovOlga Michailovna SmirnovaKononenko Vladimirovna IrinaEndocrinology Research Centrearticlepathogenesisthe insulin secretionsignaling pathwaysdrugs actionNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 18, Iss 3, Pp 23-31 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
pathogenesis the insulin secretion signaling pathways drugs action Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
pathogenesis the insulin secretion signaling pathways drugs action Nutritional diseases. Deficiency diseases RC620-627 Ivan Ivanovich Dedov Olga Michailovna Smirnova Kononenko Vladimirovna Irina New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
description |
The prevalence of type 2 diabetes is increasing dramatically, and the pathogenesis of the disease has been studied extensively in recent years. Of particular interest, incretins are reported to cause changes in insulin secretion that affect the natural development of the disease. The emergence of new drugs that act via the incretin axis have led many clinicians to consider their place in clinical practice. |
format |
article |
author |
Ivan Ivanovich Dedov Olga Michailovna Smirnova Kononenko Vladimirovna Irina |
author_facet |
Ivan Ivanovich Dedov Olga Michailovna Smirnova Kononenko Vladimirovna Irina |
author_sort |
Ivan Ivanovich Dedov |
title |
New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
title_short |
New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
title_full |
New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
title_fullStr |
New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
title_full_unstemmed |
New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
title_sort |
new concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications |
publisher |
Endocrinology Research Centre |
publishDate |
2015 |
url |
https://doaj.org/article/5136acef822b45b6a6dddfc208a9d30d |
work_keys_str_mv |
AT ivanivanovichdedov newconceptsofglucoseinducedinsulinsecretioninthedevelopmentoftype2diabetesclinicalimplications AT olgamichailovnasmirnova newconceptsofglucoseinducedinsulinsecretioninthedevelopmentoftype2diabetesclinicalimplications AT kononenkovladimirovnairina newconceptsofglucoseinducedinsulinsecretioninthedevelopmentoftype2diabetesclinicalimplications |
_version_ |
1718429526802825216 |